Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
-
Patent number: 8287848Abstract: A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations.Type: GrantFiled: September 27, 2007Date of Patent: October 16, 2012Assignee: Tris Pharma IncInventors: Ketan Mehta, Yu-Hsing Tu, Mahendra Shah
-
Patent number: 8287897Abstract: A particulate jelly beverage which facilitates the intake of a bitter drug and/or supplement. The beverage comprises 0.1 to 15.0% bitterness-masking ingredient comprising a vegetable fat or animal fat, 5 to 20% bitterness-masking aid comprising a sugar alcohol, 0.1 to 5.0 % gellant such as an agar or carrageenan, and water as the remainder. It may optionally contain an ingredient for reducing water repellency, such as a sucrose/fatty acid ester, glycerol/fatty acid ester, or propylene glycol, in an amount of 0.01 to 1.5%.Type: GrantFiled: September 7, 2004Date of Patent: October 16, 2012Assignee: Ryukakusan Co., Ltd.Inventor: Atsuko Fukui
-
Patent number: 8287898Abstract: The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by producing a sensation of satiety in said subjects. The method of managing body weight includes administering the composition prior to food consumption, concurrent with food consumption, as replacement for food consumption and combinations thereof.Type: GrantFiled: May 3, 2005Date of Patent: October 16, 2012Assignee: The Procter & Gamble CompanyInventors: Ronald James Jandacek, Gary Robert Kelm, Satinder Singh Bharaj, Jorge Villanueva Penafiel
-
Patent number: 8282954Abstract: The present invention provides a process for making an edible film having a substantially uniform distribution of components, which includes the steps of combining a water-based film polymer solution and a slurry-type mixture comprising a water-active component and a solvent; mixing the polymer solution and slurry-type mixture for about 10 minutes or less; dispensing the mixed solution and slurry-type mixture to form a film; and drying the film to evaporate the water and solvent. Films made by the process are also provided.Type: GrantFiled: December 15, 2008Date of Patent: October 9, 2012Assignee: MonoSol Rx, LLCInventors: Beuford A. Bogue, Garry L. Myers
-
Patent number: 8283327Abstract: The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient.Type: GrantFiled: March 20, 2006Date of Patent: October 9, 2012Inventor: Bruce W. Kneller
-
Patent number: 8277836Abstract: A carbohydrate mixture for dietetic foods and pharmaceuticals is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed. Carbohydrate component A may comprise at least one monosaccharide or of at least one oligosaccharide (disaccharide to hexasaccharide) or a mixture of two or more of these saccharides. Carbohydrate component B may comprise a polysaccharide (from heptasaccharide onwards) or a mixture of two or more polysaccharides. Carbohydrate component A=5 to 95 wt-% and carbohydrate component B=5 to 95 wt-% of the sum of the carbohydrate components A+B (=100 wt-%), and at least 80 wt-% of the carbohydrates/saccharides of both carbohydrate components have a prebiotic effect. The carbohydrate mixtures have not only a nutritive effect but they also stimulate health-promoting microorganisms present in the natural flora of the large intestine.Type: GrantFiled: September 23, 2009Date of Patent: October 2, 2012Assignee: N.V. NutriciaInventors: Gunther Sawatzki, Bernd Stahl
-
Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
Patent number: 8277824Abstract: Disclosed are methods of solubilizing various coolants, in particular cyclohexane-based carboxamide derivatives to facilitate formulating these coolants into a wide variety of consumer products, including those for oral cavity, throat, skin and hair care applications. Suitable solvents are those that provide at least 5% concentrated solutions of these coolants. Particularly preferred solvents are those used in the perfume and flavor industries and are GRAS materials that do not contribute formulation difficulties or negative aesthetics.Type: GrantFiled: August 14, 2009Date of Patent: October 2, 2012Assignee: The Procter & Gamble CompanyInventor: John Christian Haught -
Patent number: 8277835Abstract: The present invention provides a method and composition for the treatment and/or prevention of infection, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and immunoglobulin from the milk or colostrum of hyperimmunized cows.Type: GrantFiled: August 24, 2005Date of Patent: October 2, 2012Assignee: N. V. NutriciaInventors: Günther Boehm, Laura M'Rabet, Bernd Stahl, Johan Garssen, Antony William Scammell, Raymonde Peter Peeters
-
Patent number: 8268305Abstract: The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.Type: GrantFiled: September 23, 2011Date of Patent: September 18, 2012Assignee: Bio-Cat, Inc.Inventors: Christopher Schuler, Edward Schuler, Christopher S. Penet, Gregory Moore, Kelly Gregory
-
Patent number: 8268961Abstract: Antibacterial peptides and their multimeric analogues, with a wide range of action and low haemolytic activity are described. In particular, the peptide molecules exhibit a high antimicrobial activity against numerous bacterial species, with reduced cytotoxicity and a low haemolysis rate. The molecules of the invention are advantageously usable as therapeutic agents and coadjutants against infections caused by strains that are resistant to common antibiotics.Type: GrantFiled: July 13, 2005Date of Patent: September 18, 2012Assignee: Universita Degli Studi di SienaInventors: Luisa Bracci, Andrea Giuliani, Alessandro Pini, Paolo Neri
-
Patent number: 8263112Abstract: The subject invention is a method and material for removing fluid from the intestinal tract of a host and may be useful in treating animals or human patients suffering from fluid overload states. In one embodiment, the subject method involves ingesting an enterically coated non-systemic, non-toxic, non-digestible, water absorbing polymer which absorbs fluid while passing through the intestinal tract. The polymer is excreted in the feces wherein the polymer and absorbed fluid is removed from the body. Preferred polymers include super absorbent acrylic acid polymers, preferably provided in bead form. The polymers may include functional groups for selectively removing blood borne waste products, e.g. urea, from the G.I. tract.Type: GrantFiled: May 6, 2004Date of Patent: September 11, 2012Assignee: Sorbent Therapeutics, Inc.Inventors: Jaime Simon, Alan D. Strickland
-
Patent number: 8252311Abstract: Black beans B are coated with a mineral layer 1 containing calcium powder and dolomite powder, a dough layer 2 formed by roasting a dough mixture containing flour, and an outside layer 3 formed by solidifying a seasoning mixture containing, for example, soymilk powder and powdered tea with hardened fat or oil. In 30 parts by weight of black beans, from 2 to 5, both inclusive, parts by weight of the calcium powder, from 30 to 45, both inclusive, parts by weight of the dolomite powder, and from 5 to 15, both inclusive, parts by weight of the soymilk powder, are contained.Type: GrantFiled: April 27, 2009Date of Patent: August 28, 2012Assignee: Ishikawa Co., Ltd.Inventors: Junji Ohtani, Ikuko Ishikawa
-
Patent number: 8252309Abstract: Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.Type: GrantFiled: October 20, 2005Date of Patent: August 28, 2012Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpAInventor: Franco Gaetani
-
Patent number: 8252310Abstract: The present invention relates to a new iron containing phosphate adsorbent and its use e.g. for treating hyperphosphataemia.Type: GrantFiled: December 10, 2007Date of Patent: August 28, 2012Assignee: Novartis AGInventors: Michael Ambühl, Corine Gessier-Vial, Christa Hartmann, Daniel Kaufmann, Ernst Küsters, Ulrich Meier, Andreas Meyer, Nabila Sekkat
-
Patent number: 8241659Abstract: The invention relates to a liquid nutrition comprising short chain fatty acyl chains and a non-digestible, fermentable saccharide. The composition is particular suitable for use as an infant nutrition. The composition is also suitable for treatment and/or prevention of gut barrier related disorders.Type: GrantFiled: January 30, 2012Date of Patent: August 14, 2012Assignee: N. V. NutriciaInventors: Gelske Speelmans, Martine Sandra Alles, Jan Knol
-
Patent number: 8241665Abstract: A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.Type: GrantFiled: October 10, 2011Date of Patent: August 14, 2012Assignee: Banner Pharmacaps, Inc.Inventors: EmadEldin M. Hassan, Warren W. Kindt, Roger E. Gordon
-
Patent number: 8241658Abstract: The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.Type: GrantFiled: July 19, 2010Date of Patent: August 14, 2012Assignee: Nestec S.A.Inventors: Glenn R. Gibson, Sofia Kolida
-
Patent number: 8231910Abstract: A method of preparing a trace element solution includes the steps of providing at least one EDTA-complex, providing a sodium selenite solution, and combining the EDTA-complex(es) and the sodium selenite solution to form a trace element solution. An EDTA complex is prepared by using disodium EDTA or EDTA acid, selenium, and any other suitable mineral.Type: GrantFiled: October 28, 2003Date of Patent: July 31, 2012Assignee: Warburton Trading LimitedInventors: Robert Naylor Laurie, Lambertus Petrus Vosloo
-
Patent number: 8231922Abstract: Disclosed is a bovine milk derived phosphatidylserine source of natural composition having excellent dispersibility and organoleptic as well as physical stability. The source is useful in neutraceutical in powder, liquid or dispersion form. The source can be prepared from serum from butter oil production or from the retentate from microfiltration of whey for defatting purposes.Type: GrantFiled: October 31, 2008Date of Patent: July 31, 2012Assignee: Arla Foods AmbaInventors: Hans Burling, Ingemar Andersson, Michael Schneider
-
Patent number: 8217084Abstract: Nutraceutical and dietary supplement formulations for delivering bioavailable thiols to a host, comprising certain organosulfur radicals, such as the allyl mercapto radical, bound to larger molecules such as proteins, resulting in the formation in the host's body of various allium-related compounds such as allicin. The formulations are produced by treating an ingestible material comprising a cysteine-containing protein with a thiol, disulfide, mixed disulfide, thiosufinate or mixed thiosulfinate so as to cause thiol residues to become disulfide bonded to cysteines contained in the protein.Type: GrantFiled: May 24, 2005Date of Patent: July 10, 2012Assignee: Allium Vitalis IncorporatedInventor: David M. Ott
-
Patent number: 8216605Abstract: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.Type: GrantFiled: October 12, 2004Date of Patent: July 10, 2012Assignee: Nestec S.A.Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
-
Patent number: 8212063Abstract: The present invention relates to a xanthophyll composition containing (trans, meso)-zeaxanthin), (trans, R,R)-zeaxanthin and (trans, R,R)-lutein useful for nutrition and health care and a process for its preparation. More particularly, the invention relates to a xanthophylls composition containing at least 80% by weight of total xanthophylls, out of which the (trans,3R,3?S, meso)-zeaxanthin content is at least 80%, the remaining being (trans, R,R)-zeaxanthin, (trans, R,R)-lutein and trace amounts of other carotenoids. This invention further provides a xanthophyll composition containing at least 80% by weight of total xanthophylls, out of which at least 50% being (trans, R,R)-zeaxanthin, the remaining being (trans,3R,3?S, meso)-zeaxanthin, (trans, R,R)-lutein and trace amounts of other carotenoids.Type: GrantFiled: May 4, 2007Date of Patent: July 3, 2012Assignee: OmniActive Health Technologies LimitedInventors: Sunil Kumar T. K., Sherena P. Abdulkadir, Shankaranarayana Madapura Lingappiah
-
Patent number: 8207109Abstract: A food supplement with a “slimming” effect is disclosed which strengthens the skeletal muscle, protecting the cardio-vascular apparatus of the user, and has as its characterising components propionyl L-carnitine, coenzyme Q10 nicotinamide, riboflavin and pantothenic acid.Type: GrantFiled: June 13, 2001Date of Patent: June 26, 2012Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpAInventor: Franco Gaetani
-
Patent number: 8206739Abstract: The present invention relates to the use of a enzyme treated fish protein hydrolyzate (FPH). The FPH material lowers the concentration of cholesterol in plasma, and triglycerides in the liver. FPH also induces a favorable change in the fatty acid pattern, and lowers the concentration of homocysteine in plasma. A preferable embodiment of the invention relates to the use of FPH as an anti-atherogenic and cardio protective agent, either given as a pharmaceutical or as a functional food.Type: GrantFiled: July 2, 2004Date of Patent: June 26, 2012Assignee: Atlantic Garden ASInventor: Rolf Berge
-
Patent number: 8207225Abstract: Novel compositions containing conjugated linoleic acids are efficacious as animal feed additives and human dietary supplements. Linoleic acid is converted to its conjugated forms in which the resulting composition is low in certain unusual isomers compared to conventional conjugated linoleic products. In addition, the inventions provides compositions that are prepared according to a novel method that controls oxidation of CLA into volatile organic compounds as well as containing metal oxidant chelators to control oxidation during storage.Type: GrantFiled: January 28, 2008Date of Patent: June 26, 2012Assignee: Aker Biomarine ASAInventors: Asgeir Saebo, Carl Skarie
-
Patent number: 8197842Abstract: A novel dietary supplement and methods for the manufacture of the same are disclosed for feeding to equines and other animals. The dietary supplement of the present invention is beneficial to the health of equines and other animals. The dietary supplement of the present invention consists of safe and natural ingredients rather than drugs, and is orally administrable. The ingredients of the dietary supplement make the dietary supplement of the present invention highly beneficial to the health of equines and other animals.Type: GrantFiled: February 9, 2010Date of Patent: June 12, 2012Assignee: Freedom Health, LLCInventors: Peter M. J. Bedding, Franklin L. Pellegrini
-
Patent number: 8198067Abstract: A microbial biomass, made from algae, bacteria, fungi, yeast, or combinations thereof, provides a feed for animals raised either in agriculture or aquaculture. A feed additive, and a therapeutic composition can also be made from a microbial biomass of algae, bacteria, fungi, yeast, or combinations thereof. The feed, feed additive, and therapeutic composition can comprise one or more proteins, peptides, antibodies, antibody fragments, or a combination thereof, wherein said proteins, peptides, antibodies, antibody fragments, or a combination thereof are non-native to the microbes of the biomass. The biomass can have therapeutic, bioactive, nutritional, and/or immunogenic properties.Type: GrantFiled: June 9, 2006Date of Patent: June 12, 2012Assignee: Advanced Bionutrtion CorporationInventor: David J. Kyle
-
Patent number: 8193211Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.Type: GrantFiled: September 30, 2005Date of Patent: June 5, 2012Assignee: Supernus Pharmaceuticals, Inc.Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
-
Patent number: 8187624Abstract: The invention relates to a composition for taking dietary fibers, which comprises 1 to 50% by weight, on the basis of the whole composition, of dietary fibers composed of water-soluble and hardly fermentable dietary fiber and water-soluble and fermentable dietary fiber, wherein the water-soluble and fermentable dietary fiber is contained in a proportion of 0.1 to 3 parts by weight per part by weight of the water-soluble and hardly fermentable dietary fiber. The composition remarkably ameliorates not only bowel movement frequency but also full consciousness, feeling of unsatisfied defecation, etc. and is hence useful as food for ameliorating bowel movement.Type: GrantFiled: June 14, 2000Date of Patent: May 29, 2012Assignee: Kao CorporationInventors: Shigeyuki Ono, Yasushi Kajihara, Yoko Sugiura, Hiroyuki Sugaya
-
Patent number: 8187613Abstract: The invention provides an allergy prevention method or treatment method, diets and oral drugs enabling prevention/treatment of allergic symptoms without trouble such as systemic adverse reaction, immune deficiency and the like caused by transdermal/intravenous administration of TGF-?. The allergy prevention method or treatment method is to orally administer 100 ?g/kg or more of transforming growth factor-beta (TGF-?) relative to a weight of an administration target body and thereby selectively suppress Th2 immune response, while with respect to the diets and oral drugs, the content is set to contain an effective amount of transforming growth factor-beta (TGF-?) therein.Type: GrantFiled: December 15, 2009Date of Patent: May 29, 2012Assignee: Yamanashi UniversityInventor: Atsuhito Nakao
-
Patent number: 8182822Abstract: The invention provides an allergy prevention method or treatment method, diets and oral drugs enabling prevention/treatment of allergic symptoms without trouble such as systemic adverse reaction, immune deficiency and the like caused by transdermal/intravenous administration of TGF-?. The allergy prevention method or treatment method is to orally administer 100 ?g/kg or more of transforming growth factor-beta (TGF-?) relative to a weight of an administration target body and thereby selectively suppress Th2 immune response, while with respect to the diets and oral drugs, the content is set to contain an effective amount of transforming growth factor-beta (TGF-?) therein.Type: GrantFiled: December 15, 2009Date of Patent: May 22, 2012Assignee: Yamanashi UniversityInventor: Atsuhito Nakao
-
Publication number: 20120121685Abstract: The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.Type: ApplicationFiled: May 11, 2010Publication date: May 17, 2012Applicant: NESTEC S.A.Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
-
Publication number: 20120107386Abstract: A composition comprising a nutrient encapsulated in a coating and a condiment is disclosed. A method of manufacturing the composition is also disclosed.Type: ApplicationFiled: May 14, 2010Publication date: May 3, 2012Applicant: VITAMINSPICE LLCInventor: Edward Bukstel
-
Patent number: 8168241Abstract: A dietary supplement for enhancing physical performance of human subjects is disclosed. The supplement in dry, finely-divided form includes as a major ingredient a soy protein isolate containing at least 80% protein on a moisture-free basis with lesser amounts of carbohydrate, free form amino acids, medium chain triglycerides, creatine monohydrate, l-carnitine, grape seed extract, coenzyme Q10, piper nigrum extract, and alpha lipoic acid. In a preferred embodiment, the supplement also includes minor amounts of conjugated linoleic acid and phosphatidylserine/phosphatidylcholine complex.Type: GrantFiled: February 18, 2004Date of Patent: May 1, 2012Assignee: Reliv International, Inc.Inventors: Carl W. Hastings, David J. Barnes, Christine A. Daley
-
Patent number: 8168170Abstract: Disclosed are compositions comprising an inner core and at least two surrounding layers. The compositions are suitable for use in humans and other mammals, particularly wherein a component of the inner core is susceptible to moisture. The compositions comprise an inner core comprising one or more components; an inner layer which surrounds the inner core, wherein the inner layer is selected from continuous coatings insoluble at a pH of about 3 or less, continuous coatings having a coating weight of from about 3 mg/cm2, and combinations thereof; and an outer layer which surrounds the inner layer, wherein the outer layer is hydrophobic.Type: GrantFiled: October 3, 2002Date of Patent: May 1, 2012Assignees: The Procter and Gamble Company, Alimentary Health Ltd.Inventor: Graham John Myatt
-
Patent number: 8163303Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and a-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and a-tocopherol equivalents are administered in a daily amount of 50-400 mg.Type: GrantFiled: September 26, 2007Date of Patent: April 24, 2012Assignee: N.V. NutriciaInventors: Maria Anna Verheul-Koot, Chantal Nelleke Kleijer, Robert Johan Joseph Hageman, Roelof Andre Bork, Maud Goethals
-
Patent number: 8148609Abstract: Methods of in vitro propagation of plants of the genus Eriodictyon are described, including, in particular embodiments, plants of the species E. californicum, E. trichocalyx and E. sessilifolium. Methods of producing transgenic plants of the genus Eriodictyon are also described, along with methods of producing recombinant proteins in such plants. Compositions and methods for administering recombinant proteins produced in these plants are also described.Type: GrantFiled: June 19, 2009Date of Patent: April 3, 2012Inventors: Hilary Koprowski, Natalia Pogrebnyak, Maxim Golovkin
-
Publication number: 20120076849Abstract: A composition based on plants for treating or preventing viral diseases of the blood, such as the diseases caused by the virus of human immunodeficiency (HIV) or hepatitis C. The composition comprises flower of sulfur, a plant containing catechin and a tannin agent, and a pharmaceutically acceptable carrier. The plant is selected from Agrimonia Eupatoria and Uncaria gambir.Type: ApplicationFiled: April 10, 2009Publication date: March 29, 2012Inventor: Sleimen El Kettany
-
Patent number: 8142809Abstract: The invention provides for a diet that significantly reduces the glycohemoglobin levels in individuals with type 2 diabetes. A diet plan can be provided to an individual in the form of cards and/or pages with an appropriate meal plan, food items and/or pre-packaged meals, or in an electronic medium for the individuals to use to develop appropriate meal plans. The diet comprises food items having a nutritional composition that consists essentially of 30% protein, 50% fats, and 20% carbohydrates, or food items having a nutritional composition that consists essentially of 30% protein, 40% fats, and 30% carbohydrates.Type: GrantFiled: August 25, 2005Date of Patent: March 27, 2012Assignees: Regent of the Univ. of Minnesota, The United States of America as represented by the Department of Veterans AffairsInventors: Mary C. Gannon, Frank Nuttall
-
Patent number: 8143062Abstract: Compositions for enhancing satiety and weight loss in an individual, assays for assessing a tastant for enhancing satiety and weight loss, and methods of using the composition to suppress appetite and enhance weight loss are provided.Type: GrantFiled: November 27, 2002Date of Patent: March 27, 2012Inventor: Alan R. Hirsch
-
Patent number: 8137691Abstract: The present invention provides methods for feeding older sows that beneficially reduce feed intake in older sows, yet improve pig survival and weaning weight of pigs from older sows.Type: GrantFiled: February 25, 2009Date of Patent: March 20, 2012Assignee: APC, Inc.Inventors: Joe David Crenshaw, Joy Campbell, Louis E. Russell
-
Patent number: 8137690Abstract: The teachings provided herein generally relate to formulations, systems, and methods that have the ability to remit deficiencies and imbalances in a subject's serotonin and dopamine levels. The teachings relate to the preparation and uses of a formulation comprising a serotonergic agent or dopaminergic agent in a form capable of oral transmucosal delivery to a subject. The formulation includes a flavoring agent and a carrier base. The flavoring agent functions as a taste indicator of the endpoint of a taste titration of the serotonergic or dopaminergic agent for a subject receiving an oral administration of the formulation in the form of a taste titration, and the endpoint is indicated to the subject by a change in the intensity of the flavor of the flavoring agent.Type: GrantFiled: January 16, 2009Date of Patent: March 20, 2012Assignee: Health Innovations, LLCInventor: Pietr Hitzig
-
Publication number: 20120064143Abstract: Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules.Type: ApplicationFiled: November 11, 2009Publication date: March 15, 2012Applicant: The Board of Regents of the University of Texas SystemInventors: Zelton Dave Sharp, John R. Strong, Veronica Galvan, Salvatore Oddo, Herbert G. Wheeler
-
Publication number: 20120058172Abstract: Compounds obtainable from plants, e.g. of the genus Eucalyptus, or from microorganisms are shown to be useful as CNS activity modulators useful e.g. in the treatment of depression, for lifting mood and/or for increasing behavioural initiative and the like. This use and related aspects form embodiments of the invention. Also compounds as such are presented. The compounds useful are acylphloroglucine derivatives of the formula I, wherein the substituents are as defined in the description.Type: ApplicationFiled: November 11, 2011Publication date: March 8, 2012Applicant: Intermed Discovery GmbHInventors: Ernst Roemer, Torsten Grothe
-
Patent number: 8128956Abstract: A pet food product for hairball treatment that includes a shell component completely surrounding an inner component to form one dual textured pet food product, wherein the shell component is harder than the inner component. The shell component can include a mixture of soluble and insoluble fiber and can include at least one ingredient comprising a carbohydrate, fat, protein or combination thereof. The inner component comprises a mixture of ingredients, wherein the ingredients include a lubricant.Type: GrantFiled: September 10, 2004Date of Patent: March 6, 2012Assignee: Mars, Inc.Inventors: Allan A. Torney, Kasim A. Zubair, Liisa Mooney, Frank Shields, Tiffany L. Bierer
-
Patent number: 8128955Abstract: Disclosed is a solid or semi-solid foodstuff for human consumption, the foodstuff comprising creatine suspended in solid form in an edible supporting matrix; the foodstuff being in the form of a bar.Type: GrantFiled: May 28, 2004Date of Patent: March 6, 2012Assignee: The Original Creatine Patent CompanyInventors: Alan N. Howard, Roger C. Harris
-
Patent number: 8124121Abstract: The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers, —savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.Type: GrantFiled: October 23, 2008Date of Patent: February 28, 2012Assignee: Senomyx, Inc.Inventors: Catherine Tachdjian, Andrew P. Patron, Sara L. Adamski-Werner, Farid Bakir, Qing Chen, Vincent Darmohusodo, Stephen Terrence Hobson, Xiaodong Li, Ming Qi, Daniel H. Rogers, Marketa Rinnova, Guy Servant, Xiao-Qing Tang, Mark Zoller, David Wallace, Amy Xing, Klaus Gubernator
-
Patent number: 8119155Abstract: The invention relates to a liquid nutrition comprising short chain fatty acyl chains, polyunsaturated fatty acyl chains, vegetable oil and a non-digestible, fermentable saccharide. The composition is particular suitable for use as an infant nutrition. The composition is also suitable for treatment and/or prevention of gut barrier related disorders.Type: GrantFiled: April 21, 2006Date of Patent: February 21, 2012Assignee: N. V. NutriciaInventors: Gelske Speelmans, Martine Sandra Alles, Jan Knol
-
Patent number: 8116842Abstract: A process, apparatus, and method for online control and database collection and management of a computerized detection, tracking, and feedback control system. The system tests for nutrients by Raman scattering effects on skin or other tissues to determine the content of carotenoids or other nutrients as evidenced in that skin. Serum levels of nutrients may vary dramatically with time, but skin tissues may average such nutrition over time. Skin and other tissues may be scanned with light to produce accurate measurements of carotenoids or other nutrients accumulated in the skin based on the Raman scattering affect of those nutrients in the skin. A score can be derived from a properly calibrated bio-photonic scanner to reflect an averaged effective uptake of the detected nutrient (e.g. such as the carotenoid example).Type: GrantFiled: December 2, 2010Date of Patent: February 14, 2012Assignee: NSE Products, Inc.Inventors: John Fralick, Kathy L. Chapman, legal representative, David L. Breiter, Jack Peterson, Mindy Gilbert, Marvin Distel, Ryan Newman, Joel Erickson
-
Patent number: RE43582Abstract: The subject invention is a carrier or product formed of a matrix having starch, sugar, fat, polyhydric alcohol and water in suitable ratios such that there exists a water activity of 0.6-0.75. The water activity of the product matrix may be adjusted up or down so that the availability of water in the finished product is not detrimental to the included active ingredient, be it pharmaceutical, nutraceutical, or a vitamin mineral complex.Type: GrantFiled: April 29, 2009Date of Patent: August 14, 2012Assignee: EZ-Med Holdings, Inc.Inventor: Edwin H. Christensen